Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32

• المؤلفون الرئيسيون: Kang Wu (مؤلف), Jun Zeng (مؤلف), Xulian Shi (مؤلف), Jiajia Xie (مؤلف), Yuqing Li (مؤلف), Haoxiang Zheng (مؤلف), Guoyu Peng (مؤلف), Guanghui Zhu (مؤلف), Dongdong Tang (مؤلف), Song Wu (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2022-01-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Bladder cancer is a highly metastatic tumor and one of the most common malignancies originating in the urinary tract. Despite the efficacy of immune checkpoints, including programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), the effect of immunotherapy for bladder...